Antitumor agents. 2. Synthesis, structure - Activity relationships, and biological evaluation of substituted 5H-pyridophenoxazin-5-ones with potent antiproliferative activity

Journal of Medicinal Chemistry

Volumn 45, Issue 24, 2002, Pages 5217-5223

  Bolognese, Adele ^a   Correale, Gaetano ^a   Manfra, Michele ^a   Lavecchia, Antonio ^a   Mazzoni, Orazio ^a   Novellino, Ettore ^a   Barone, Vincenzo ^a   La Colla, Paolo ^b   Loddo, Roberta ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5H BENZOPHENOXAZIN 5 ONE; 5H PYRIDO[3,4 A]PHENOXAZIN 5 ONE; 5H PYRIDO[4,3 A]PHENOXAZIN 5 ONE; 5H PYRIDOPHENOXAZIN 5 ONE; ANTINEOPLASTIC AGENT; BENZOPHENOXAZINE; DACTINOMYCIN; NITROGEN; PHENOXAZINE DERIVATIVE; POLYCYCLIC HYDROCARBON; PYRIDINE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGY; CELL LINE; CELL PROLIFERATION; CYTOTOXICITY; DNA BINDING; ELECTRON; EVALUATION; HUMAN; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OXAZINES; QUANTUM THEORY; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0037153229     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020918w     Document Type: Article

References (20)

1. Morton, R. A., Ed. Biochemistry of Quinones; Academic Press: New York, 1965.
2. Wakelin, L. P. G.; Waring, M. J. DNA intercalating agents. In Comprehensive Medicinal Chemistry; Sammes, P. G., Ed.; Pergamon Press: Oxford, U.K., 1990; Vol. 2, pp 703-724.
3. Chabner, B. A.; Allegra, C. J.; Curt, G. A.; Calabresi, P. Antineoplastic agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed.; Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., Gilman, A. G., Eds.; McGraw-Hill: New York, 1996; pp 1233-1287.
4. Lown, J. W. Anthracycline and Anthracenedione-Based Anticancer Agents; Elsevier: Amsterdam, 1988.
5. Carter, S. K.; Crooke, S. T. Mitomycin C: Current Status and New Developments; Academic Press: New York, 1979.
6. Rao, K. V.; Cullen, W. P. Streptonigrin, an antitumor substance, I. Isolation and characterization. Antibiot. Ann. 1959, 950-953.
7. Liquori, A. M.; DeLerma, B.; Ascoli, F.; Transciatti, M. Interaction between DNA and polycyclic aromatic hydrocarbons. J. Mol. Biol. 1962, 5, 521-526.
8. Miller, E. C.; Miller, J. A. Mechanisms of chemical carcinogenesis. Cancer 1981, 47, 1055-1064.
9. Bolognese, A.; Correale, G.; Manfra, M.; Lavecchia, A.; Mazzoni, O.; Novellino, E.; Barone, V.; Pani, A.; Tramontano, E.; La Colla, P.; Murgioni, C.; Serra, I.; Setzu, G.; Loddo, R. Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido [3,2-a] phenoxazin-5-one, a compound with potent antiproliferative activity. J. Med. Chem. 2001, 45, 5205-5216.
10. 13C chemical shift data of some ommochrome models: Substituted benzo[3,2-a]-5H-phenoxazin-5-one. Heterocycles 1992, 34, 1829-1833.
11. Nan'ya, S.; Maekawa, E.; Hayakawa, H.; Kitaguchi, Y.; Ueno, Y. Synthesis of 5H-pyrido[2,3-a]phenoxazin-5-one and 5H-pyrido[3,2-a]phenoxazin-5-one derivatives. J. Heterocycl. Chem. 1985, 22, 1483-1885.
12. Barret, R.; Daudon, M. Synthesis of quinonimines with iodoxybenzene. Synth. Commun. 1990, 20, 1543-1549.
13. Fleming, I. Frontier Orbitals and Organic Chemical Reactions; John Wiley & Sons: Chichester, U.K. 1976.
14. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A., Jr.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Adamo, C.; Jaramillo, J.; Cammi, R.; Pomelli, C.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian 99, Development Version, Revision C.01; Gaussian, Inc.: Pittsburgh, PA, 2000.
15. Adamo, C.; Barone, V. Toward realiable density functional without adjustable parameters: The PBE0 model. J. Chem. Phys. 1999, 110, 6158-6170.
16. Adamo, C.; Cossi, M.; Barone, V. An accurate density functional method for the study of magnetic properties. The PBE0 model. THEOCHEM 1999, 493, 145-157.
17. Foresman, J. B.; Frisch, A.; Exploring Chemistry with Electronic Structure Methods, 2nd Ed.; Gaussian Inc., Pittsburgh, PA, 1998.
18. Adamo, C.; Cossi, M.; Rega, N.; Barone, V. In New Computational Strategies for the Quantum Mechanical Study of Biological Systems in Condensed Phases, in Theoretical Biochemistry Processes and Properties of Biological Systems, Theoretical and Computational Chemistry; Eriksson, L. A., Ed.; Elsevier Science B. D.: New York, 2001; Vol. 9, pp 467-538.
19. Martin R. B. In Metal Ions in Biological Systems; Sigel, H., Ed.; Dekker: New York, 1985; Vol. 19.
20. Nakazawa, H.; Chou, F. E.; Andrews, P. A.; Bachur, N. R. Chemical reduction of actnomicyn D and phenoxazone analogues to free radicals. J. Org. Chem. 1981, 46, 1493-1496.